GPT and metabolic dysfunction-associated steatotic liver disease: In younger and middle-aged people, long-term increases in serum ALT activity are caused, for example, by non-alcoholic fatty liver disease [25,26], but eventually, the hepatic transaminase activities of the patients may become low during the terminal stage of cirrhosis because of lower ALT synthesis in the liver.